Ranked #3,359 of 8,699 institutional investors
Sphera Funds Management Ltd.
Tel Aviv, L3
$576M
US stock portfolio at live prices · today −$2.0M (−0.35%)
Market closed. Prices as of Nov 20, 9:11 AM ET
- Value at quarter end (Q3 2026)
- $660M
- Change from Q2 2026
- −$37.5M (−5.37%)
- Positions
- 88 · 17 new, 14 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: call options on $16.7M of stock, put options on $30.3M. $119M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesBBIO 4.23%BIIB 3.25%MLYS 3.25%CYTK 3.23%BMRN 3.13%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| BBIO BridgeBio Pharma, Inc. | 311,717 | $24.4M | 4.23% | Added +27% |
| BIIB Biogen Inc. | 75,763 | $18.7M | 3.25% | Reduced −22% |
| MLYS Mineralys Therapeutics, Inc. | 1,321,861 | $18.7M | 3.25% | Reduced −10% |
| CYTK Cytokinetics, Incorporated | 361,897 | $18.6M | 3.23% | Added +65% |
| BMRN BioMarin Pharmaceutical Inc. | 293,246 | $18.0M | 3.13% | Reduced −11% |
| ALNY Alnylam Pharmaceuticals, Inc. | 120,602 | $17.8M | 3.10% | Added +1,017% |
| SOXX iShares Semiconductor ETF | 111,000 | $15.3M | 2.66% | New |
| COGT Cogent Biosciences, Inc. | 501,540 | $13.9M | 2.42% | Added +9% |
| SNY Sanofi | 269,515 | $12.4M | 2.16% | Unchanged |
| MAZE Maze Therapeutics, Inc. | 366,288 | $11.9M | 2.06% | Reduced −12% |
| LLY Eli Lilly and Company | 8,040 | $10.9M | 1.89% | Unchanged |
| MDGL Madrigal Pharmaceuticals, Inc. | 25,795 | $10.2M | 1.78% | Added +48% |
| META Meta Platforms, Inc. | 16,200 | $9.7M | 1.68% | New |
| RYTM Rhythm Pharmaceuticals, Inc. | 80,400 | $9.4M | 1.63% | Unchanged |
| SNDX Syndax Pharmaceuticals, Inc. | 1,007,278 | $9.2M | 1.60% | Reduced −1% |
| IRON Disc Medicine, Inc. | 114,738 | $8.7M | 1.52% | Added +81% |
| PFE Pfizer Inc. | 286,000 | $7.9M | 1.37% | Unchanged |
| JNJ Johnson & Johnson | 28,831 | $7.7M | 1.34% | Unchanged |
| TRAX First Tracks Biotherapeutics, Inc. | 160,237 | $7.1M | 1.24% | Added +475% |
| VOR Vor Biopharma Inc. | 383,417 | $7.1M | 1.23% | Reduced −8% |
| TNGX Tango Therapeutics, Inc. | 304,250 | $6.9M | 1.20% | Added +20% |
| NVS Novartis AG | 45,000 | $6.8M | 1.18% | Reduced −10% |
| MRK Merck & Co., Inc. | 48,600 | $6.5M | 1.12% | Reduced −17% |
| NVCT Nuvectis Pharma, Inc. | 323,425 | $6.4M | 1.11% | Reduced −16% |
| KLAC KLA Corporation | 45,220 | $6.4M | 1.11% | New |
| ABBV AbbVie Inc. | 22,256 | $6.3M | 1.10% | Reduced −26% |
| ABVX ABIVAX Société Anonyme | 73,716 | $5.9M | 1.03% | New |
| RARE Ultragenyx Pharmaceutical Inc. | 338,643 | $5.8M | 1.01% | Reduced −42% |
| IDYA IDEAYA Biosciences, Inc. | 211,408 | $5.5M | 0.96% | Added +8% |
| TRVI Trevi Therapeutics, Inc. | 385,329 | $5.3M | 0.92% | Reduced −23% |
| LRCX Lam Research Corporation | 25,900 | $5.3M | 0.92% | Added +40% |
| AMAT Applied Materials, Inc. | 14,300 | $4.8M | 0.84% | Added +30% |
| NVO Novo Nordisk A/S | 120,677 | $4.7M | 0.81% | Unchanged |
| ELVN Enliven Therapeutics, Inc. | 99,765 | $4.6M | 0.80% | Reduced −12% |
| GSK GSK plc | 90,000 | $4.3M | 0.75% | Reduced −12% |
| SVRA Savara Inc. | 802,645 | $4.2M | 0.73% | Added +6% |
| ANNX Annexon, Inc. | 1,222,687 | $4.2M | 0.72% | New |
| TECX Tectonic Therapeutic, Inc. | 187,438 | $3.9M | 0.68% | New |
| CLYM Climb Bio Inc | 416,747 | $3.9M | 0.67% | Reduced −14% |
| QTTB Q32 Bio Inc. | 448,873 | $3.8M | 0.66% | New |
| OVID Ovid Therapeutics Inc. | 1,600,000 | $3.7M | 0.65% | Added +18% |
| RLAY Relay Therapeutics, Inc. | 233,836 | $3.7M | 0.65% | Unchanged |
| MSLE Satellos Bioscience Inc. | 638,690 | $3.7M | 0.64% | Reduced −2% |
| ACOG Alpha Cognition Inc. | 415,554 | $3.7M | 0.64% | Reduced −24% |
| SRRK Scholar Rock Holding Corporation | 72,265 | $3.6M | 0.63% | Reduced −23% |
| RVMD Revolution Medicines, Inc. | 22,400 | $3.6M | 0.62% | Unchanged |
| DYN Dyne Therapeutics, Inc. | 222,564 | $3.6M | 0.62% | Added +12% |
| ACAD Acadia Pharmaceuticals Inc. | 202,087 | $3.6M | 0.62% | Reduced −43% |
| LRMR Larimar Therapeutics, Inc. | 1,035,004 | $3.3M | 0.58% | Added +12% |
| TENX Tenax Therapeutics, Inc. | 2,315,696 | $3.2M | 0.56% | Added +1,827% |
| HRMY Harmony Biosciences Holdings, Inc. | 95,763 | $3.2M | 0.55% | Reduced −46% |
| CRVS Corvus Pharmaceuticals, Inc. | 298,161 | $3.0M | 0.52% | Added +22% |
| EVMN Evommune Inc | 390,632 | $2.8M | 0.49% | Added +1,626% |
| PRLD Prelude Therapeutics Incorporated | 844,832 | $2.7M | 0.48% | Reduced −17% |
| ORIC ORIC Pharmaceuticals, Inc. | 349,383 | $2.7M | 0.47% | Reduced −54% |
| ELDN Eledon Pharmaceuticals, Inc. | 1,392,187 | $2.6M | 0.46% | Added +17% |
| AMGN Amgen Inc. | 6,000 | $2.6M | 0.46% | Reduced −20% |
| CLDX Celldex Therapeutics, Inc. | 91,096 | $2.5M | 0.44% | Reduced −62% |
| LTGO Latigo Biotherapeutics, Inc. | 192,120 | $2.5M | 0.44% | New |
| IMMX Immix Biopharma, Inc. | 355,800 | $2.5M | 0.43% | Added +32% |
| RAPP Rapport Therapeutics, Inc. | 100,000 | $2.4M | 0.41% | New |
| PALI Palisade Bio, Inc. | 2,464,038 | $2.3M | 0.40% | Added +9% |
| ANL Adlai Nortye Group Ltd. | 235,664 | $2.1M | 0.37% | New |
| WVE Wave Life Sciences, Inc. | 747,272 | $2.0M | 0.35% | Added +17% |
| CTNM Contineum Therapeutics, Inc. | 221,379 | $2.0M | 0.35% | Added +21% |
| KURA Kura Oncology, Inc. | 267,539 | $2.0M | 0.34% | Reduced −9% |
| JBIO Jade Biosciences, Inc. | 105,529 | $1.6M | 0.28% | New |
| AVTX Avalo Therapeutics, Inc. | 234,968 | $1.6M | 0.28% | Added +1% |
| ERAS Erasca, Inc. | 109,200 | $1.6M | 0.27% | New |
| CABA Cabaletta Bio, Inc. | 1,263,612 | $1.3M | 0.22% | Reduced −5% |
| AAOI Applied Optoelectronics, Inc. | 32,210 | $1.3M | 0.22% | New |
| PYXS Pyxis Oncology, Inc. | 689,000 | $1.2M | 0.20% | New |
| TSHA Taysha Gene Therapies, Inc. | 250,000 | $943K | 0.16% | Unchanged |
| IKT Inhibikase Therapeutics, Inc. | 688,301 | $895K | 0.16% | Added +6% |
| BBOT BridgeBio Oncology Therapeutics, Inc. | 464,480 | $864K | 0.15% | Added +1% |
| BIOA BioAge Labs, Inc. | 182,562 | $860K | 0.15% | Reduced −15% |
| NTLA Intellia Therapeutics, Inc. | 90,250 | $859K | 0.15% | New |
| PMN ProMIS Neurosciences, Inc. | 254,782 | $818K | 0.14% | Reduced −22% |
| QNRX Quoin Pharmaceuticals, Ltd. | 236,234 | $794K | 0.14% | New |
| UPB Upstream Bio, Inc. | 325,831 | $652K | 0.11% | Added +48% |
| HOWL Werewolf Therapeutics, Inc. | 626,810 | $618K | 0.11% | Unchanged |
| SRZN Surrozen, Inc. | 18,821 | $577K | 0.10% | New |
| VYGR Voyager Therapeutics, Inc. | 214,554 | $345K | <0.1% | Reduced −50% |
| ORGO Organogenesis Holdings Inc. | 330,000 | $260K | <0.1% | Reduced −40% |
| CTMX CytomX Therapeutics, Inc. | 125,395 | $257K | <0.1% | Reduced −86% |
| APRE Aprea Therapeutics, Inc. | 270,000 | $133K | <0.1% | Unchanged |
| TRAW Traws Pharma, Inc. | 398,486 | $92K | <0.1% | Unchanged |
| SKYE Skye Bioscience, Inc. | 87,264 | $69K | <0.1% | Added +3% |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| INSM Insmed Incorporated | 118,800 | $17.2M |
| KOD Kodiak Sciences Inc. | 81,796 | $8.0M |
| ZBIO Zenas BioPharma, Inc. | 230,834 | $5.8M |
| CLOU Global X Cloud Computing ETF | 195,900 | $4.9M |
| VSTM Verastem, Inc. | 632,632 | $4.3M |
| TLN Talen Energy Corporation | 12,135 | $4.3M |
| XENE Xenon Pharmaceuticals Inc. | 105,000 | $3.9M |
| VST Vistra Corp. | 29,450 | $3.7M |
| BCRX BioCryst Pharmaceuticals, Inc. | 422,051 | $3.1M |
| GENB Generate Biomedicines, Inc. | 245,000 | $2.5M |
| CEG Constellation Energy Corporation | 9,850 | $2.5M |
| ORA Ormat Technologies, Inc. | 28,015 | $2.5M |
| GPCR Structure Therapeutics Inc. | 28,600 | $490K |
| STTK Shattuck Labs, Inc. | 86,461 | $393K |